Results 1 to 10 of about 360,596 (308)

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

open access: yesActa Dermato-Venereologica, 2023
Clinical trials showed that upadacitinib, a selective Janus kinase-1 inhibitor, is effective for treatment of moderate-to-severe atopic dermatitis. However, daily practice studies are limited.
Celeste M. Boesjes   +8 more
doaj   +1 more source

Determination of the Frequency of Scalp Basal Cell Carcinoma Subtypes Based on Histopathology and Other Related Variables and its Comparison between Patients with and without Chronic Radio-Dermatitis [PDF]

open access: yesMiddle East Journal of Cancer, 2022
Background: Basal cell carcinoma (BCC) is the most prevalent type of skin cancer in Iran. The determination of subtype of BCC plays an essential role in the diagnosis, recurrence rate, and outcome of patients.
Farideh Jowkar   +6 more
doaj   +1 more source

Oral food challenges in children [PDF]

open access: yesKorean Journal of Pediatrics, 2011
Many patients assume that allergic reactions against foods are responsible for triggering or worsening their allergic symptoms. Therefore, it is important to identify patients who would benefit from an elimination diet, while avoiding unnecessary dietary
Hye Yung Yum   +9 more
doaj   +1 more source

Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry

open access: yesActa Dermato-Venereologica, 2021
Dupilumab treatment improves signs, symptoms, and quality of life in patients with moderate-to-severe atopic dermatitis. This study evaluated the impact of dupilumab treatment on absenteeism, presenteeism, and related costs in a large multi-centre cohort
Lieneke F.M. Ariëns   +9 more
doaj   +1 more source

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

open access: yesClinical and Translational Allergy, 2023
Background The patho‐mechanism of ocular surface disease (OSD) in dupilumab‐treated atopic dermatitis (AD) patients remains unclear. The aim of this study is to measure dupilumab levels in tear fluid and serum, and relate these findings to the severity ...
Roselie Achten   +13 more
doaj   +1 more source

Allergic contact dermatitis from sculptured acrylic nails: special presentation with an airborne pattern

open access: yesDermatology Reports, 2012
Methylmethacrylate was first reported in 1941 as a cause of contact dermatitis. Since then, occupational contact allergies to acrylates in dentistry, orthopedic surgery, printing industry and industry have been reported, but few reports are found in the ...
Paula Maio   +4 more
doaj   +1 more source

Elaboration and Validation of Flowchart for the Prevention and Treatment of Intestinal Peristomal Skin Complications

open access: yesJournal of Coloproctology, 2021
Objective To build and validate a flowchart for the prevention and treatment of intestinal peristomal skin complications. Method For the construction of the algorithms, a systematic review was carried out in health sciences databases ...
Imaculada Aparecida Cardoso   +4 more
doaj   +1 more source

Proderm technology: a water- based lipid delivery system for dermatitis that penetrates viable epidermis and has antibacterial effects. [PDF]

open access: yes, 2019
BackgroundA defective skin barrier and bacterial colonization are two important factors in maintenance and progression of atopic dermatitis and chronic allergic/irritant hand dermatitis.
Caputo-Janhager, Melinda   +4 more
core   +3 more sources

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis. [PDF]

open access: yes, 2020
Dupilumab is a fully human antibody to interleukin-4 receptor α that improves the signs and symptoms of moderate to severe atopic dermatitis (AD). To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversity on the ...
Ardeleanu, Marius   +16 more
core   +2 more sources

Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey [PDF]

open access: yes, 2020
Background. The purpose of this study was to gather information on the current assessment and management of patients with moderate-to-severe AD in routine daily practice. Methods.
Armario Hita, José Carlos   +9 more
core   +3 more sources

Home - About - Disclaimer - Privacy